Market Research Logo

Global Medical Imaging Reagents Market 2017-2021

Global Medical Imaging Reagents Market 2017-2021

About Medical Imaging Reagents

Medical imaging reagents are substances that are designed to enhance the imaging of specific organs, tissues, diseases, and physiological functions using medical imaging equipment to diagnose and monitor diseases. Medical imaging reagents are used in a wide range of imaging modalities such as X-ray, computed tomography (CT), ultrasound, single photon emission computed tomography (SPECT), positron emission tomography (PET), and magnetic resonance imaging (MRI). Imaging reagents have improved the quality of medical imaging examinations.

Technavio’s analysts forecast the global medical imaging reagents market to grow at a CAGR of 8.57% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global medical imaging reagents market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Medical Imaging Reagents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Bayer
  • Bracco Diagnostics
  • GE Healthcare
  • Guerbet Group
  • Lantheus Medical Imaging
Other prominent vendors
  • Cardinal Health
  • Curium
  • DONGKOOK
  • Eli Lilly and Company
  • Isologic Innovative Radiopharmaceuticals
  • Jiangsu Hengrui Medicine
  • Piramal Imaging
  • SHINE Medical Technologies
Market driver
  • Rising incidence of cardiovascular disorders and cancer
  • For a full, detailed list, view our report
Market challenge
  • High cost of developing imaging reagents
  • For a full, detailed list, view our report
Market trend
  • Increasing number of strategic collaborations
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Medical Imaging Reagents Market 2017-2021

Technavio recognizes the following companies as the key players in the global medical imaging reagents market: Bayer, Bracco Diagnostics, GE Healthcare, Guerbet Group, and Lantheus Medical Imaging.

Other Prominent Vendors in the market are: Cardinal Health, Curium, DONGKOOK, Eli Lilly and Company, Isologic Innovative Radiopharmaceuticals, Jiangsu Hengrui Medicine, Piramal Imaging, and SHINE Medical Technologies.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increasing number of strategic collaborations. Strategic collaborations are becoming common in the global medical imaging reagents market. Many vendors are engaging in strategic collaborations to enhance their product development capabilities and strengthen their market position.”

According to the report, one driver in the market is rising incidence of cardiovascular disorders and cancer. The global incidence of CVDs such as angina, myocardial infarction, stroke, heart failure, venous thromboembolism, heart arrhythmia, and their associated risk factors are increasing. CVDs are estimated to cause approximately 19 million deaths across the world by 2020. In 2013, nearly 1.9 million people died due to CVD in the European Union (EU). According to the Centers for Disease Control and Prevention (CDC), in the US, approximately 610,000 people die from heart disease every year. Annually, about 735,000 people in the US have a heart attack.

Further, the report states that one challenge in the market is high cost of developing imaging reagents. The average time taken to develop diagnostic drugs is approximately 10 years. It costs $150 million. The sales of imaging agent can range between $100 million and $500 million. The time taken to develop a therapeutic drug is around 15 years. It costs between $800 million and $900 million. However, therapeutic drugs can generate sales of nearly $3.5 billion. Therefore, the return on investment from the commercialization of imaging agents is significant when compared with therapeutic drugs.

Companies Mentioned

Bayer, Bracco Diagnostics, GE Healthcare, Guerbet Group, and Lantheus Medical Imaging, Cardinal Health, Curium, DONGKOOK, Eli Lilly and Company, Isologic Innovative Radiopharmaceuticals, Jiangsu Hengrui Medicine, Piramal Imaging, and SHINE Medical Technologies.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Overview
  • Market landscape
    • Overview
      • Table Global medical imaging reagents market: Segmentation
    • Market size and forecast
      • Table Global medical imaging reagents market 2016-2021 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Segmentation by product type
    • Overview
      • Table Global medical imaging reagents market: Segmentation by product type 2016 (%share)
    • Contrast reagents
      • Table Global contrast reagents market 2016-2021 ($ millions)
      • Table Global contrast reagents market: Segmentation by product type 2016 (% share)
      • Table Major iodinated contrast reagents
      • Table Global Iodinated contrast reagents market 2016-2021 ($ millions)
      • Table Major gadolinium contrast reagents
      • Table Global gadolinium contrast reagents market 2016-2021 ($ millions)
      • Table Global barium-based contrast reagents market 2016-2021 ($ millions)
      • Table Major microbubbles contrast reagents
      • Table Global microbubbles contrast reagents market 2016-2021 ($ millions)
    • Nuclear imaging reagents
      • Table Major nuclear imaging reagents
      • Table Global nuclear imaging reagents market 2016-2021 ($ millions)
  • Segmentation by geography
    • Overview
      • Table Global medical imaging reagents market: Segmentation by geography 2016 (%share)
    • Americas
      • Table Medical imaging reagents market in Americas 2016-2021 ($ millions)
    • EMEA
      • Table Medical imaging reagents market in EMEA 2016-2021 ($ millions)
    • APAC
      • Table Medical imaging reagents market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Number of MRI exams performed by hospitals and ASCs per 1,000 people 2013-2015
      • Table Number of CT exams performed by hospitals and ASCs per 1,000 people 2013-2015
    • Market challenges
  • Market trends
    • Increasing number of strategic collaborations
    • Increasing number of product approvals
    • Increasing R&D focus on nanotechnology-based imaging reagents
  • Vendor landscape
    • Competitive landscape
      • Table Global medical imaging reagents market: Competitive structure analysis 2016
  • Key vendor analysis
    • Bayer
      • Table Bayer: Key highlights
      • Table Bayer: Strength assessment
      • Table Bayer: Strategy assessment
      • Table Bayer: Opportunity assessment
    • Bracco Diagnostics
      • Table Bracco Diagnostics: Key highlights
      • Table Bracco Diagnostics: Strength assessment
      • Table Bracco Diagnostics: Strategy assessment
      • Table Bracco Diagnostics: Opportunity assessment
    • GE Healthcare
      • Table GE Healthcare: Key highlights
      • Table GE Healthcare: Strength assessment
      • Table GE Healthcare: Strategy assessment
      • Table GE Healthcare: Opportunity assessment
    • Guerbet Group
      • Table Guerbet Group: Key highlights
      • Table Guerbet Group: Strength assessment
      • Table Guerbet Group: Strategy assessment
      • Table Guerbet Group: Opportunity assessment
    • Lantheus Medical Imaging
      • Table Lantheus Medical Imaging: Key highlights
      • Table Lantheus Medical Imaging: Strength assessment
      • Table Lantheus Medical Imaging: Strategy assessment
      • Table Lantheus Medical Imaging: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report